EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identification of 2 Novel Subtypes of Hepatitis C Virus Genotype 8 and a Potential New Genotype Successfully Treated With Direct Acting Antivirals

Jean L Mbisa iD, Zena Lapp, David F Bibby, Laura T Phillips, Carmen F Manso, Simon Packer, Ruth Simmons, Kathryn Harris, Jaiganesh Mohan, Lalitha Chinnappan, Thomas Leitner, Daniel Bradshaw

The Journal of Infectious Diseases · 16.12.2024 · 230 (6) · e1254-e1262

DOI: 10.1093/infdis/jiae253 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Infectious Diseases, online erschienen am 08.05.2024. Verfasst von Jean L Mbisa und 11 weiteren Autor:innen. Beteiligte Einrichtung: Virus Reference Department, UK Health Security Agency, London, United Kingdom. Hauptthemen laut MEDLINE: Hepacivirus, Antiviral Agents, Genotype. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute for Health and Care, Los Alamos National Laboratory, Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hepatitis C virus (HCV) has high genetic diversity and is classified into 8 genotypes and >90 subtypes, with some endemic to specific world regions. This could compromise direct-acting antiviral efficacy and global HCV elimination.

Methods

We characterized HCV subtypes “rare” in the United Kingdom (non-1a/1b/2b/3a/4d) by means of whole-genome sequencing via a national surveillance program. Genetic analyses to determine the genotype of samples with unresolved genotypes were undertaken by comparison with International Committee on Taxonomy of Viruses HCV reference sequences.

Results

Two HCV variants were characterized as being closely related to the recently identified genotype (GT) 8, with >85% pairwise genetic distance similarity to GT8 sequences and within the typical intersubtype genetic distance range. The individuals infected by the variants were UK residents originally from Pakistan and India. In contrast, a third variant was only confidently identified to be more similar to GT6 compared with other genotypes across 6% of the genome and was isolated from a UK resident originally from Guyana. All 3 were cured with pangenotypic direct-acting antivirals (sofosbuvir-velpatasvir or glecaprevir-pibrentasvir) despite the presence of resistance polymorphisms in NS3 (80K/168E), NS5A (28V/30S/62L/92S/93S) and NS5B (159F).

Conclusions

This study expands our knowledge of HCV diversity by identifying 2 new GT8 subtypes and potentially a new genotype.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HepacivirusAntiviral AgentsGenotypeHumansUnited KingdomPhylogenyMaleSofosbuvirWhole Genome SequencingQuinoxalinesCarbamatesGenetic VariationHepatitis CHeterocyclic Compounds, 4 or More RingsHepatitis C, ChronicFemaleGenome, ViralMiddle AgedBenzimidazolesAdult

Stichwörter der Autor:innen

DAA therapyHCVgenetic diversitygenotype classificationwhole-genome sequencing

Substanzen

Antiviral AgentsSofosbuvirQuinoxalinesCarbamatesHeterocyclic Compounds, 4 or More RingsBenzimidazoles

Autor:innen und Institutionen

  • Virus Reference Department, UK Health Security Agency, London, United Kingdom.
  • National Institute for Health and Care Research Health Protection Research Unit (NIHR HPRU) in Bloodborne and Sexually Transmitted Infections, London, United Kingdom.
  • Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, New Mexico, USA.
  • Royal London Hospital, Barts Health NHS Trust, London, United Kingdom.
  • Warrington and Halton Teaching Hospitals NHS Foundation Trust, Warrington, United Kingdom.

ORCID-Profile: Jean L Mbisa

Förderung

  • National Institute for Health and Care
  • Los Alamos National Laboratory
  • Research
  • NIH HHS
  • NIAID NIH HHS
  • Health Protection Research Unit
  • National Institutes of Health

Zitieren

APA

Mbisa, J. L., Lapp, Z., Bibby, D. F., Phillips, L. T., Manso, C. F., Packer, S., Simmons, R., Harris, K., Mohan, J., Chinnappan, L., Leitner, T., & Bradshaw, D. (2024). Identification of 2 Novel Subtypes of Hepatitis C Virus Genotype 8 and a Potential New Genotype Successfully Treated With Direct Acting Antivirals. The Journal of Infectious Diseases, 230(6), e1254-e1262. https://doi.org/10.1093/infdis/jiae253

Vancouver

Mbisa JL, Lapp Z, Bibby DF, Phillips LT, Manso CF, Packer S, et al. Identification of 2 Novel Subtypes of Hepatitis C Virus Genotype 8 and a Potential New Genotype Successfully Treated With Direct Acting Antivirals. The Journal of Infectious Diseases. 2024;230(6):e1254-e1262. doi:10.1093/infdis/jiae253

BibTeX
@article{Mbisa2024,
  author = {Mbisa, Jean L and Lapp, Zena and Bibby, David F and Phillips, Laura T and Manso, Carmen F and Packer, Simon and Simmons, Ruth and Harris, Kathryn and Mohan, Jaiganesh and Chinnappan, Lalitha and Leitner, Thomas and Bradshaw, Daniel},
  title = {Identification of 2 Novel Subtypes of Hepatitis C Virus Genotype 8 and a Potential New Genotype Successfully Treated With Direct Acting Antivirals},
  journal = {The Journal of Infectious Diseases},
  year = {2024},
  volume = {230},
  number = {6},
  pages = {e1254--e1262},
  doi = {10.1093/infdis/jiae253}
}
Kostenlos starten →